Africa Clinical Trials Market Size, Share & Industry Analysis, By Phase (Phase I, Phase II, Phase III, and Phase IV), By Application (Oncology, CNS Disorder, Cardiology, Infectious Disease, Metabolic Disorder, Renal/Nephrology, and Others), and Regional Forecast, 2024-2032

Last Updated: February 10, 2025 | Format: PDF | Report ID: FBI110939

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2023
Estimated Year	2024
Forecast Period	2024-2032
Historical Period	2019-2022
Growth Rate	CAGR of 7.2% from 2024-2032
Unit	Value (USD billion)
Segmentation	By Phase Phase I Phase II Phase III Phase IV
	By Application Oncology CNS Disorder Cardiology Infectious Disease Metabolic Disorder Renal/Nephrology Others
	By Region West Africa (by Phase, by Application, and by Country/Sub-region) Senegal (by Phase and by Application) Mali (by Phase and by Application) Burkina Faso (by Phase and by Application) Cote d’Ivoire (by Phase and by Application) Ghana (by Phase and by Application) Gambia (by Phase and by Application) Nigeria (by Phase and by Application) Rest of West Africa (by Phase and by Application) Central Africa (by Phase, by Application, and by Country/Sub-region) Cameroon (by Phase and by Application) Congo & DRC (by Phase and by Application) Gabon (by Phase and by Application) Republic of Central Africa (by Phase and by Application) Rest of Central Africa (by Phase and by Application) East Africa (by Phase, by Application, and by Country/Sub-region) Kenya (by Phase and by Application) Uganda (by Phase and by Application) Tanzania (by Phase and by Application) Rest of East Africa (by Phase and by Application) South Africa (by Phase, by Application, and by Country/Sub-region) Angola (by Phase and by Application) South Africa (by Phase and by Application) Mozambique (by Phase and by Application) Rest of South Africa (by Phase and by Application)